Inventor · disambiguated record
Brett Chevalier
Also filed as: CHEVALIER BRETT · CHEVALIER BRETT SMITH
10 granted patents·16 pending applications·17 citations·filing 2006–2025
86Inventor score
Files withINVETX INC14WHITEHEAD INST BIOMEDICAL RES5BERRY DAVID A2SAMPLE6 TECHNOLOGIES INC2CAMP4 THERAPEUTICS CORP1
Top patents by PatentIndex Score
26 records- 0194US11498953B2Compositions for increasing half-life of a therapeutic agent in felines and methods of useINVETX INC·Filed 2021·Granted Nov 15, 2022·6 cites·21 claims
- 0291US11434276B2Polypeptides with altered binding to neonatal Fc receptor (FcRn) and methods of useINVETX INC·Filed 2021·Granted Sep 6, 2022·2 cites·13 claims
- 0390US11739135B2Compositions for increasing half-life of a therapeutic agent in felines and methods of useINVETX INC·Filed 2022·Granted Aug 29, 2023·1 cites·9 claims
- 0485US2024166749A1Compositions for increasing half-life of a therapeutic agent in canines and methods of useINVETX INC·Filed 2024·Application pending·0 cites
- 0585US2024239896A1Compositions for increasing half-life of a therapeutic agent in canines and methods of useINVETX INC·Filed 2024·Application pending·0 cites
- 0685US2024166748A1Compositions for increasing half-life of a therapeutic agent in canines and methods of useINVETX INC·Filed 2024·Application pending·0 cites
- 0785US2024239897A1Compositions for increasing half-life of a therapeutic agent in canines and methods of useINVETX INC·Filed 2024·Application pending·0 cites
- 0883US2023279359A1Wnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factorsWHITEHEAD INST BIOMEDICAL RES·Filed 2022·Application pending·0 cites
- 0981US2023279118A1Compositions for increasing half-life of a therapeutic agent in canines and methods of useINVETX INC·Filed 2022·Application pending·0 cites
- 1080US2025304650A1Compositions for increasing half-life of a therapeutic agent in felines and methods of useINVETX INC·Filed 2025·Application pending·0 cites
- 1179US12344650B2Compositions for increasing half-life of a therapeutic agent in felines and methods of useINVETX INC·Filed 2022·Granted Jul 1, 2025·0 cites·18 claims
- 1279USRE49281EWnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factorsWHITEHEAD INST BIOMEDICAL RES·Filed 2019·Granted Nov 8, 2022·1 cites·8 claims
- 1378US9102919B2WNT pathway stimulation in reprogramming somatic cells with nuclear reprogramming factorsCHEVALIER BRETT·Filed 2008·Granted Aug 11, 2015·4 cites·12 claims
- 1477US2024327497A1Compositions for increasing half-life of a therapeutic agent in canines and methods of useINVETX INC·Filed 2024·Application pending·0 cites
- 1575US9234227B2Recombinant phage and methodsSAMPLE6 TECHNOLOGIES INC·Filed 2012·Granted Jan 12, 2016·2 cites·8 claims
- 1673US9593311B2Wnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factorsWHITEHEAD INST BIOMEDICAL RES·Filed 2015·Granted Mar 14, 2017·1 cites·8 claims
- 1771US11542333B2Compositions for increasing half-life of a therapeutic agent in canines and methods of useINVETX INC·Filed 2020·Granted Jan 3, 2023·0 cites·9 claims
- 1871US2023127241A1Compositions for increasing half-life of a therapeutic agent in canines and methods of useINVETX INC·Filed 2022·Application pending·0 cites
- 1970US11548949B2Compositions for increasing half-life of a therapeutic agent in canines and methods of useINVETX INC·Filed 2020·Granted Jan 10, 2023·0 cites·7 claims
- 2066US2019284537A1Wnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factorsWHITEHEAD INST BIOMEDICAL RES·Filed 2019·Application pending·0 cites
- 2160US2017218341A1Wnt pathway stimulation in reprogramming somatic cells with nuclear reprogramming factorsWHITEHEAD INST BIOMEDICAL RES·Filed 2017·Application pending·0 cites
- 2256US2009047295A1Methods and Compositions for Reducing Stemness in OncogenesisBERRY DAVID A·Filed 2008·Application pending·0 cites
- 2352US2011044895A1Methods and compositions for reducing stemness in oncogenesisBERRY DAVID A·Filed 2010·Application pending·0 cites
- 2446US2007208518A1User interface for presentation of genomic dataGORDON DAVID B·Filed 2006·Application pending·0 cites
- 2545US2016122729A1Recombinant phage and methodsSAMPLE6 TECHNOLOGIES INC·Filed 2016·Application pending·0 cites
- 2641US2021254056A1Identification and targeted modulation of gene signaling networksCAMP4 THERAPEUTICS CORP·Filed 2018·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →